Co-Diagnostics, Inc. Common Stock (CODX NASDAQ) stock market data APIs
$3.3306
0.4(12%)
as of June 17, 2026
Try our APIs with
free plan!
Co-Diagnostics, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Prev. Close
3.3306
Open
3.7318
High
3.8428
Low
2.9679
52 wk Range
1.26-46.5
Market Cap
13 820 K
Shares Outstanding
3 685 K
Revenue
718 K
EPS
-4.0894
Beta
1.264
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Co-Diagnostics, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Co-Diagnostics, Inc. Common Stock data using free add-ons & libraries
Get Co-Diagnostics, Inc. Common Stock Fundamental Data
Co-Diagnostics, Inc. Common Stock Fundamental data includes:
- Net Revenue: 718 K
- EBITDA: -30 836 742
- Earnings Per Share: -32
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Co-Diagnostics, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-04-01
- EPS/Forecast: -3.75
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Co-Diagnostics, Inc. Common Stock News
New
Co-Diagnostics And CoSara Advance Development Of Ebola PCR Test And Point-of-Care Platform; Stock Up
(RTTNews) - Co-Diagnostics Inc. (CODX) and its joint venture CoSara Diagnostics Pvt. Ltd. announced progress in developing a PCR-based diagnostic test for Ebola virus, alongside enhancements to the Co...
Pre Market Movers: GNTA, HCWC, ZCMD Set The Path
(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday, suggesting potential breakout opportunities. Assessing sentiment and momentum in the premarket sets the tone for ...
Top Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest
(RTTNews) - In Thursday's list of gainers, we highlight SciSparc, which received the regulatory go-ahead to acquire a stake in a private Israeli technology company, Co-Diagnostics, which extended its ...
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
Joint development strategy has been developed to address international deployment requirements if current outbreak continues or expands globally SALT LAKE CITY, May 26, 2026 /PRNewswire/ -- Co-Diagno...
Get Co-Diagnostics, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
